Literature DB >> 30651719

Correction to: Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.

Xin-Xin Cao1, Hao Cai1, Yue-Ying Mao1, Qi Wu1, Lu Zhang1, Dao-Bin Zhou1, Jian Li1.   

Abstract

[This corrects the article DOI: 10.1186/s12935-018-0716-7.].

Entities:  

Year:  2019        PMID: 30651719      PMCID: PMC6330738          DOI: 10.1186/s12935-019-0736-y

Source DB:  PubMed          Journal:  Cancer Cell Int        ISSN: 1475-2867            Impact factor:   5.722


Correction to: Cancer Cell Int (2018) 18:215 10.1186/s12935-018-0716-7

Following publication of the original article [1], we have been notified that the data in Fig. 1 was wrongly presented. The correct Fig. 1 is presented below.
Fig. 1

Circos plots depicting the relative frequencies and pairwise co-occurrences of selected common genetic alterations: in all AML patients (a), separately in patients 60 years or older (b) and in patients younger than 60 years (c). The length of the arc corresponds to the frequency of the first gene mutation, and the width of the ribbon corresponds to the proportion of co-occurrence with the second gene mutation. Both the distribution of gene mutations and the pattern of mutation co-occurrences appear to be distinct between older and younger AML patients

Circos plots depicting the relative frequencies and pairwise co-occurrences of selected common genetic alterations: in all AML patients (a), separately in patients 60 years or older (b) and in patients younger than 60 years (c). The length of the arc corresponds to the frequency of the first gene mutation, and the width of the ribbon corresponds to the proportion of co-occurrence with the second gene mutation. Both the distribution of gene mutations and the pattern of mutation co-occurrences appear to be distinct between older and younger AML patients
  1 in total

1.  Next-generation sequencing-based genetic landscape and its clinical implications for Chinese acute myeloid leukemia patients.

Authors:  Xin-Xin Cao; Hao Cai; Yue-Ying Mao; Qi Wu; Lu Zhang; Dao-Bin Zhou; Jian Li
Journal:  Cancer Cell Int       Date:  2018-12-22       Impact factor: 5.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.